No false start for novel pseudotyped vectors

Current Opinion in Biotechnology

Volumn 13, Issue 5, 2002, Pages 437-442

  Sanders, David Avram ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENVELOPE PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LENTIVIRUS VECTOR; MEMBRANE ANTIGEN; RECOMBINANT DNA; RETROVIRUS VECTOR; VIRUS DNA; VIRUS GLYCOPROTEIN; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; AMINO ACID SEQUENCE; AVIAN SARCOMA VIRUS; BIRD DISEASE; CARBOXY TERMINAL SEQUENCE; DNA PACKAGING; FELINE IMMUNODEFICIENCY VIRUS; GENE REPLICATION; GENE TRANSFER; GENETIC TRANSDUCTION; HELPER VIRUS; HEPATITIS B VIRUS; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE SYSTEM; LEUKEMIA VIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLONEY LEUKEMIA ONCOVIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; ROSS RIVER ALPHA VIRUS; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS ENVELOPE; VIRUS GENE; VIRUS RECOMBINANT; VISNA VIRUS;

ADENO-ASSOCIATED VIRUS; ALPHAVIRUS; AVES; AVIAN SARCOMA VIRUS; DNA VIRUSES; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; ONCOVIRINAE; ROSS RIVER VIRUS; SIMPLEXVIRUS; UNIDENTIFIED RETROVIRUS; VESICULAR STOMATITIS VIRUS; VISNA VIRUS;

EID: 0036811514     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(02)00374-9     Document Type: Review

References (41)

1. Pearson M.N., Rohrmann G.F. Transfer, incorporation, and substitution of envelope fusion proteins among members of the Baculoviridae, Orthomyxoviridae, and Metaviridae (insect retrovirus) families. J Virol. 76:2002;5301-5304. A minireview of insect viral glycoproteins and their transfer between virus families. Viral evolution through recombination and consequent natural pseudotyping.
2. Sharkey C.M., North C.L., Kuhn R.J., Sanders D.A. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J Virol. 75:2001;2653-2659. First report of the production of and transduction by recombinant alphavirus-glycoprotein pseudotyped retroviruses. Favorable properties as well as stable producer cells are described. Pseudotyped viruses used to probe cell biology of alphavirus entry.
3. Miletic H., Bruns M., Tsiakas K., Vogt B., Rezai R., Baum C., Kuhlke K., Cosset F.L., Ostertag W., Lother H., et al. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol. 73:1999;6114-6116.
4. Beyer W.R., Miletic H., Ostertag W., von Laer D. Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference. J Virol. 75:2001;1061-1064.
5. Beyer W.R., Westphal M., Ostertag W., von Laer D. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol. 76:2002;1488-1495. Description of advantageous properties of recombinant arenavirus glycoprotein-pseudotyped retroviruses.
6. Pinter A., Kopelman R., Li Z., Kayman S.C., Sanders D.A. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active site sequence of thiol-disulfide exchange enzymes. J Virol. 71:1997;8073-8077.
7. Sanders D.A. Sulfhydryl involvement in fusion mechanisms. Hilderson H., Fuller S. Fusion of Biological Membranes and Related Problems. 2000;483-514 Kluwer Academic/Plenum Publishers, New York.
8. Opstelten D.J., Wallin M., Garoff H. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J Virol. 72:1998;6537-6545.
9. Pickl W.F., Pimentel-Muinos F.X., Seed B. Lipid rafts and pseudotyping. J Virol. 75:2001;7175-7183.
10. Sung V.M., Lai M.M. Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system. J Virol. 76:2002;912-917.
11. Bruett L., Clements J.E. Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism. J Virol. 75:2001;11464-11473. Evaluation of glycoprotein cytoplasmic domain properties that are advantageous for pseudotype production.
12. Lewis B.C., Chinnasamy N., Morgan R.A., Varmus H.E. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J Virol. 75:2001;9339-9344.
13. Engelstadter M., Buchholz C.J., Bobkova M., Steidl S., Merget-Millitzer H., Willemsen R.A., Stitz J., Cichutek K. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins. Gene Ther. 8:2001;1202-1206.
14. Matsuura Y., Tani H., Suzuki K., Kimura-Someya T., Suzuki R., Aizaki H., Ishii K., Moriishi K., Robison C.S., Whitt M.A., et al. Characterization of pseudotype VSV possessing HCV envelope proteins. Virology. 286:2001;263-275.
15. Buonocore L., Blight K.J., Rice C.M., Rose J.K. Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol. 76:2002;6865-6872.
16. Tang J., Yang T., Ghosh H.P., Geller A.I. Helper virus-free HSV-1 vectors packaged both in the presence of VSV G protein and in the absence of HSV-1 glycoprotein B support gene transfer into neurons in the rat striatum. J Neurovirol. 7:2001;548-555.
17. Lotery A.J., Derksen T.A., Russell S.R., Mullins R.F., Sauter S., Affatigato L.M., Stone E.M., Davidson B.L. Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors. Hum Gene Ther. 13:2002;689-696.
18. Mazarakis N.D., Azzouz M., Rohll J.B., Ellard F.M., Wilkes F.J., Olsen A.L., Carter E.E., Barber R.D., Baban D.F., Kingsman S.M., et al. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet. 10:2001;2109-2121.
19. Kang Y., Stein C.S., Heth J.A., Sinn P.L., Penisten A.K., Staber P.D., Ratliff K.L., Shen H., Barker K.C., Martins I., et al. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol. 76:2002;9378-9388. First report of in vivo application of recombinant alphavirus-glycoprotein pseudotyped lentiviruses for gene transfer. Efficient transduction of liver and brain glial cells observed with no apparent toxicity.
20. Yan Z., Zak R., Luxton G.W., Ritchie T.C., Bantel-Schaal U., Engelhardt J.F. Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J Virol. 76:2002;2043-2053.
21. Rabinowitz J.E., Rolling F., Li C., Conrath H., Xiao W., Xiao X., Samulski R.J. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol. 76:2002;791-801.
22. Kasahara N., Dozy A.M., Kan Y.W. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science. 266:1994;1373-1376.
23. Lavillette D., Russell S.J., Cosset F.L. Retargeting gene delivery using surface-engineered retroviral vector particles. Curr Opin Biotechnol. 12:2001;461-466. Very good review appropriately focusing mainly, although not exclusively, on the authors' efforts in the field.
24. Reynolds P.N., Nicklin S.A., Kaliberova L., Boatman B.G., Grizzle W.E., Balyasnikova I.V., Baker A.H., Danilov S.M., Curiel D.T. Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo. Nat Biotechnol. 19:2001;838-842.
25. Peng K.W., Pham L., Ye H., Zufferey R., Trono D., Cosset F.L., Russell S.J. Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors. Gene Ther. 8:2001;1456-1463.
26. Gollan T.J., Green M.R. Redirecting retroviral tropism by insertion of short, nondisruptive peptide ligands into envelope. J Virol. 76:2002;3558-3563. This and the accompanying article examine the effects of inserting short peptide ligands at various places in the Mo-MuLV Env upon transduction tropism. Promising results were obtained.
27. Gollan T.J., Green M.R. Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands. J Virol. 76:2002;3564-3569.
28. Ohno K., Sawai K., Iijima Y., Levin B., Meruelo D. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol. 15:1997;763-767.
29. Morizono K., Bristol G., Xie Y.M., Kung S.K., Chen I.S. Antibody-directed targeting of retroviral vectors via cell surface antigens. J Virol. 75:2001;8016-8020. Utilization of virus pseudotyped with modified alphaviral glycoproteins containing the IgG-binding domains of protein A for targeting cells expressing particular cell-surface antigens. The report provides support for the proposition that these glycoproteins have important advantages as frameworks for the outer shells of targeted retroviruses.
30. Rai S.K., DeMartini J.C., Miller A.D. Retrovirus vectors bearing jaagsiekte sheep retrovirus Env transduce human cells by using a new receptor localized to chromosome 3p21.3. J Virol. 74:2000;4698-4704.
31. Rai S.K., Duh F.M., Vigdorovich V., Danilkovitch-Miagkova A., Lerman M.I., Miller A.D. Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci USA. 98:2001;4443-4448. Identification of receptor through use of pseudotyped retrovirus. Pseudotyped virus also has potential for use in gene transduction of the lung.
32. Chan S.Y., Empig C.J., Welte F.J., Speck R.F., Schmaljohn A., Kreisberg J.F., Goldsmith M.A. Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell. 106:2001;117-126.
33. Chowers M.Y., Spina C.A., Kwoh T.J., Fitch N.J., Richman D.D., Guatelli J.C. Optimal infectivity in vitro of human immunodeficiency virus type 1 requires an intact nef gene. J Virol. 68:1994;2906-2914.
34. Chazal N., Singer G., Aiken C., Hammarskjold M.L., Rekosh D. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J Virol. 75:2001;4014-4018.
35. Burns J.C., Friedmann T., Driever W., Burrascano M., Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA. 90:1993;8033-8037.
36. Ory D.S., Neugeboren B.A., Mulligan R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA. 93:1996;11400-11406.
37. Liu M.L., Winther B.L., Kay M.A. Pseudotransduction of hepatocytes by using concentrated pseudotyped vesicular stomatitis virus G glycoprotein (VSV-G)-Moloney murine leukemia virus-derived retrovirus vectors: comparison of VSV-G and amphotropic vectors for hepatic gene transfer. J Virol. 70:1996;2497-2502.
38. Gallardo H.F., Tan C., Ory D., Sadelain M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood. 90:1997;952-957.
39. DePolo N.J., Reed J.D., Sheridan P.L., Townsend K., Sauter S.L., Jolly D.J., Dubensky T.W. Jr. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther. 2:2000;218-222.
40. Alvarez C.P., Lasala F., Carrillo J., Muniz O., Corbi A.L., Delgado R. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol. 76:2002;6841-6844.
41. Lavillette D., Marin M., Ruggieri A., Mallet F., Cosset F.L., Kabat D. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol. 76:2002;6442-6452.